Back to search results

Neo-Bio-ADAURA: a Phase II Study to Evaluate Mechanisms of Resistance to Neoadjuvant Osimertinib

Israel
RecruitingPHASE2

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Non-squamous NSCLC

Locations
  • Sheba Medical Center, Ramat Gan, Israel, Israel
  • Sheba Medical Center, Jusidman Cancer Center, Ramat Gan, Israel, Israel
View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)